A clinical trial to evaluate the influence of Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) – Cranberry toothpastes in changing the bacterial composition of dental plaque deposits on teeth of orthodontic patients.
- Conditions
- Dental cariesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12618000095268
- Lead Sponsor
- Prof. Laurence Walsh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 90
(1)Undergoing fixed orthodontic treatment in both arches, with treatment having been underway for at least 1 month, (2) A minimum of 10 years of age and at least 4 fully erupted permanent maxillary anterior teeth. (3) Good general physical health as determined by a review of the medical history, (4) Available to attend a review appointment in 4 weeks, and (5) Not currently using antibiotics or any antibacterial/anti-plaque mouth rinses.
(1) Any medical condition or disability preventing normal manual tooth brushing, (2) Allergy to milk casein proteins or intolerance to any of the components of the CPP-ACP toothpastes, (3) Unwillingness to use a fluoridated dentifrice, (4) Untreated periodontal disease, (5) Clinical evidence of active caries.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study assessed whether the test toothpastes could effect a beneficial change in the bacterial load numbers of 14 key bacterial species (8 cariogenic and 6 health-associated bacterial species) in the dental plaque of trial participants over the 5-6 week trial period.<br><br>Molecular microbiological analysis of dental plaque samples will be done using real-time quantitative polymerase chain reaction (qPCR) by 16S rRNA sequencing of the relevant plaque bacteria. <br><br>It is hypothesized that using the test toothpastes will result in reduced bacterial loads of 'harmful' cariogenic bacteria and increased bacterial loads of 'healthy' commensal bacteria. [5-6 weeks after baseline appointment]
- Secondary Outcome Measures
Name Time Method one[Nil]